Triple Therapy Improves Survival in Unresectable Hepatocellular Carcinoma Across Major Subgroups
A meta-analysis of 31 studies demonstrates that combining transarterial chemoembolization with targeted anti-VEGF agents and immune checkpoint inhibitors significantly extends ...





